Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
about
Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluationSustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
P2860
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@ast
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@en
type
label
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@ast
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@en
prefLabel
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@ast
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@en
P2093
P1476
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery.
@en
P2093
P304
P356
10.1080/0265204031000093591
P577
2003-05-01T00:00:00Z